![Mathieu Simon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathieu Simon
Direktor/Vorstandsmitglied bei
IDORSIA LTD
Vermögen: 543 345 $ am 31.05.2026
Profil
Dr. Mathieu Simon ist Chairman bei Epsilen Bio SRL, Chairman bei Idorsia Ltd., unabhängiges Mitglied des Verwaltungsrats bei Asarina Pharma AB, unabhängiges Mitglied des Verwaltungsrats bei Vaximm AG, Chairman bei Idorsia Pharmaceuticals Ltd., Chief Executive Officer bei Cellectis Therapeutics und unabhängiges Mitglied des Verwaltungsrats bei LNC Therapeutics SA. Er ist Mitglied des Board of Directors bei Lysogene SA, Asarina Pharma AB, Affimed NV, Affimed GmbH, Vaximm AG, Messier Maris & Associs SCA und LNC Therapeutics SA. Dr. Simon war zuvor als EVP, Chief Operating & Medical Officer bei Cellectis SA, als Vice President-Marketing & Medical Affairs bei Wyeth Pharmaceuticals LLC, als Group VP-Marketing & Clinical Affairs bei Wyeth-Ayerst International, Inc., als Senior Vice President-Global Operations bei Pierre Fabre Mdicament SAS, als Managing Director & Head-Global Pharma bei Pierre Fabre SA und als Chairman & Chief Executive Officer bei Takara Bio Europe AB tätig. Außerdem war er Vorstandsmitglied bei Alliance for Regenerative Medicine, Ectycell SASU und Farmindustria.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IDORSIA LTD. 0.04% | 31.12.2024 | 95’061 ( 0.04% ) | 543 345 $ | 31.05.2026 |
Aktuelle Nachrichten zu Mathieu Simon
Aktive Positionen von Mathieu Simon
| Unternehmen | Position | Beginn |
|---|---|---|
| IDORSIA LTD | Direktor/Vorstandsmitglied | 13.06.2024 |
Aileens Pharma Srl
 Aileens Pharma Srl Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Vorsitzender | - |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Vorsitzender | 13.05.2020 |
Messier Maris & Associés SCA
 Messier Maris & Associés SCA Investment ManagersFinance Provides financial consulting and investment advisory services | Direktor/Vorstandsmitglied | - |
Epsilen Bio Srl
 Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Develops therapies for genetic diseases | Vorsitzender | 15.06.2020 |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Direktor/Vorstandsmitglied | 01.01.2018 |
Ehemalige bekannte Positionen von Mathieu Simon
| Unternehmen | Position | Ende |
|---|---|---|
| AFFIMED N.V. | Direktor/Vorstandsmitglied | 26.06.2024 |
| CELLECTIS S.A. | Technik-/Wissenschafts-/F&E-Leiter | 14.03.2018 |
Cellectis Therapeutics | Vorstandsvorsitzender | 01.02.2014 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Mathieu Simon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
22
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 22 |
|---|---|
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Pierre Fabre SA
 Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Manufactures cosmetics and pharmaceutical products | Health Technology |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Université Paris Diderot-Paris 7
 Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Commercial Services |
Asarina Pharma AB
 Asarina Pharma AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Messier Maris & Associés SCA
Messier Maris & Associés SCA Investment ManagersFinance Provides financial consulting and investment advisory services | Finance |
Ectycell SASU
 Ectycell SASU BiotechnologyHealth Technology Produces and sales stem cells | Health Technology |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology Develops therapeutic solutions for metabolic and cardiometabolic disorders | Health Technology |
Wyeth-Ayerst International LLC | |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Farmindustria
 Farmindustria Miscellaneous Commercial ServicesCommercial Services Operates as a healthcare organization | Commercial Services |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Aileens Pharma Srl
Aileens Pharma Srl Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Commercial Services |
Epsilen Bio Srl
Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Develops therapies for genetic diseases | Health Technology |
Cellectis Therapeutics |
